Glycans exist at the surface of neural cells primarily as modifications to proteins and lipids. The broad range of functions attributed to neural glycans reflects the immense diversity of glycan structures found in neural tissue. Most glycan functions can be sorted into three non-exclusive categories: ligand, modulatory, and/or co-receptor. Classic models, that have proposed functions for glycans as adhesive ligands, are evolving to incorporate sometimes subtle, but extremely robust, effects on cell survival, differentiation, and physiology. Over the past decade, the identification of new glycan structures and unsuspected biosynthetic pathways has demonstrated that glycans modulate cell-signaling pathways and function as co-receptors for receptor-ligand interactions. In some contexts, the distinction between adhesion and signaling has become blurred. This review summarizes major recent advances in neuroglycobiology related to glycan expression and function.
ABSTRACT
Glycans exist at the surface of neural cells primarily as modifications to proteins and lipids. The broad range of functions attributed to neural glycans reflects the immense diversity of glycan structures found in neural tissue. Most glycan functions can be sorted into three non-exclusive categories: ligand, modulatory, and/or co-receptor. Classic models, that have proposed functions for glycans as adhesive ligands, are evolving to incorporate sometimes subtle, but extremely robust, effects on cell survival, differentiation, and physiology. Over the past decade, the identification of new glycan structures and unsuspected biosynthetic pathways has demonstrated that glycans modulate cell-signaling pathways and function as co-receptors for receptor-ligand interactions. In some contexts, the distinction between adhesion and signaling has become blurred. This review summarizes major recent advances in neuroglycobiology related to glycan expression and function.
INTRODUCTION AND SCOPE
Every eukaryotic cell is enveloped within a rich coating of carbohydrate known as the glycocalyx. Formed of the pendant oligosaccharide moieties of glycoproteins, glycolipids and proteoglycans, the composition of the glycocalyx is highly regulated. Specific cell types display unique glycan profiles in response to their environment and in parallel with differentiation or transformation, demonstrating both the epigenetic and programmed nature of complex carbohydrate expression (1-3). Such regulated, diverse, and cell-specific glycan expression has repeatedly generated proposals that cell surface carbohydrates function in cell-cell interactions in multiple tissues and contexts (4, 5) .
Since the specificity of cell-cell interactions is of immense significance to the formation and function of the nervous system, neurobiology has served as a fertile incubator for developing concepts in carbohydrate function. Glycan expression is dynamic and diverse. Cells express characteristic glycan profiles depending on their state of differentiation, unique identity, or physiologic status. A hypothetic lineage choice is presented in which a progenitor cell (a), expressing a signature glycan profile, differentiates into hypothetical daughter cell types (b,c), each with their own portfolio of glycans. Some structures are shared and some are unique, providing the potential for generating an overlapping, combinatorial code that establishes cellular identity.
In all figures, glycan decorations on proteins or cell surfaces represent unique molecular shapes, but are not meant to imply defined structures.
The past decade has witnessed considerable growth in the attention paid to neural carbohydrate function (6-10). Much of the newest data reinforces earlier suggestions that carbohydrates can function as ligands for endogenous carbohydrate binding proteins (lectins). However, it has also become increasingly apparent that glycans modulate the activity of the proteins to which they are attached and also function as co-receptors in protein-mediated cell-cell interactions. After a brief overview of specific glycan expression in the nervous system, this review will consider proposed mechanisms by which the receptor-ligand, modulatory, and co-receptor functions of carbohydrates contribute to cell-cell interactions in neural tissue (Table 1) . Some intriguing glycan-mediated phenomena are not discussed in this review due to space and thematic constraints. In particular, neither the emerging barrier functions of chondroitin sulfate proteoglycans in limiting axon outgrowth during CNS development/regeneration (11-14) nor the pleiotropic roles of glycosphingolipids in modulating signal transduction (15, 16) are discussed here. Extremely useful reviews of these excluded topics are available elsewhere (17-22).
CARBOHYDRATE MARKERS
It was first suggested over 30 years ago that the diversity of cell surface glycan expression could be harnessed to yield cell-type specific markers that might function as unique identity tags (Figure 1) (23, 24) . This proposal predicted the existence of cell surface protein receptors capable of interpreting and translating the glycan code into differential adhesion. In the intervening years, much effort has been directed towards identifying such lectins and their cognate carbohydrate ligands. The characteristic anatomy of the nervous system, in which functionally distinct cell types are organized into identifiable architectonic zones, laminae, and nuclei, has proven useful for demonstrating cell-specific expression of potential glycan ligands.
Nervous tissue has been a favored starting material for carbohydrate structural chemists pursuing unique glycans. The use of neural tissues has been driven, in large part, by their enriched content of interesting glycoconjugate classes relative to other tissues (25-30). For instance, the gangliosides, a structurally diverse family of sialic acid-bearing glycosphingolipids, are concentrated in the nervous system where they account for up to 50% of total cell-surface sialic acid (31). Starting in the 1980's, immunologic screens undertaken to identify cell-specific markers began to yield carbohydrate-directed monoclonal antibodies (3, 27, 32-37). In some instances monoclonal antibodies were specifically raised against neural tissue. In others, monoclonal antibodies raised against extra-neural tissue exhibited intriguing staining patterns when applied to the nervous system. In both cases, monoclonal antibody probes provided unprecedented resolution in defining carbohydrate distributions.
The heterogeneous nature of the sensory modalities carried by afferents from dorsal root ganglia (DRG) to the dorsal horn of the spinal cord has provided one landscape in which monoclonal antibodies reveal cellspecific glycan expression. DRG neurons that convey particular sensory components, or that utilize specific neurotransmitters, are also labeled by the expression of shared carbohydrate epitopes (38). Furthermore, some terminal fields within architectonic regions of the spinal cord, which receive afferent input from glycan-defined DRG neurons, exhibit coordinated carbohydrate expression (39). This observation has led to the suggestion that the specificity of neural projections could, at least in part, arise from systems-matching between complementary pairs of recognition glycans and appropriate receptors.
The existence of such a recognition mechanism is supported by the demonstration of carbohydrate binding protein (galectins, see below) expression by DRG neurons.
The terrain of the CNS and PNS is now rich with examples of intriguingly distributed carbohydrate epitopes. Many of these glycans have been characterized in reasonable detail and constitute a diverse group of structures. Several are glycolipid-associated epitopes. For instance, the Jones antigen (O-acetylated GD3 ganglioside), the HNK-1 antigen (also found on glycoprotein oligosaccharides), Lewis x glycans, globoside and specific ganglioside oligosaccharide moieties all exhibit discrete temporal or spatial distributions (27, 32, 34, 35) . Glycoprotein oligosaccharide and glycosaminoglycan epitopes also demonstrate cell-type or developmental stage specificity in their expression (29, 32, 33, (40) (41) (42) (43) (44) (45) . In model systems, such as Drosophila melanogaster and the medicinal leech (Hirudo medicinalis), the same themes of cell-type and developmental stage-specific expression have emerged although glycan structures are only now being elucidated (46-53). Proteins involved in neural development, organization, or signaling are listed alongside the glycan structures or glycan classes with which they have been demonstrated to interact. Glycan functions are distributed into non-exclusive categories: Ligand, Modulator, and Co-receptor. Glycans that serve as ligands (Ligand) are either recognized (recog) or presented (presntd) by the indicated protein. Modulatory glycans (Modulator) function in three ways: in cis, the glycan is found on the indicated protein and modulates the function or signaling capacity of that protein; in trans, the glycan is found on the indicated protein and modulates the function or signaling capacity of an interacting protein; interact, the glycan is found on an interacting protein and modulates the function or signaling capacity of the interaction. Glycan co-receptors (Co-recept) facilitate (pos) or suppress (neg) signaling, either directly or indirectly, through the presentation or sequestration of pathway components. In this table, structures are indicated using the standardized representations adopted by the Consortium for Functional Glycomics and are as follows: , Gal; , Man; , Fuc; , GlcNAc; , GalNAc; , GlcA; , Sialic acid. Abbreviations are as follows: ecm, extracellular matrix; HNK-1, epitope designation for sulfoglucuronosylneolactose-containing (SGNL) glycan; HA, hyaluronic acid; PSA, polysialic acid; cer, ceramide; Ser/Thr, serine or threonine; CS, chondroitin sulfate; HS, heparan sulfate; GlcNS, glucosamine-Nsulfate; IdoA2S, iduronic acid-2-O-sulfate; GlcN6S, glucosamine-6-O-sulfate.
Figure 2.
Neural glycans serve as ligands in cell-cell and cell-matrix interactions. Galectins (a) crosslink appropriately terminated glycans found in the extracellular matrix (b) and on transmembrane receptor proteins (c). Galectin crossslinking can block intermolecular associations between receptor molecules that are necessary for signal activation (d). The I-type lectin, Siglec-4a, is expressed by oligodendrocytes (shown) and Schwann cells, where it binds axonal glycans, resulting in the stabilization of axons and the myelin sheath (e). Members of the lectican family (f) organize extracellular matrix through their amino-terminal globular domains by interacting with glycans such as hyaluronic acid (g). The lectican carboxyl-terminal globular domain has similarity to C-type lectins and may allow the lectican to bind cell surface glycans in addition to peptide determinants. Lectican family members are themselves proteoglycans, bearing chondroitin sulfate and other glycans in cell-and stage-specific patterns (h). The functions of several carbohydrate binding activities, identified biochemically or through cell adhesion assays, remain unassigned (i).
In some instances, distinct functions have been associated with specifically expressed glycans (54-58). Mostly, however, antibody and chemical demonstrations of restricted glycan distributions provide only tantalizing suggestions that carbohydrates might function as specific recognition markers in the nervous system. One way that neural cells might harness restricted glycan expression for recognition would require that oligosaccharides function as cell-specific adhesive ligands. Although carbohydratecarbohydrate interactions generate intercellular adhesion in specific contexts (59-61), significantly greater effort has been focused on identifying proteinaceous receptors that bind and discriminate between oligosaccharide structures.
CARBOHYDRATE LIGANDS
Oligosaccharide synthetic enzymes (glycosyltransferases) could, in the absence of donor substrates, act as lectins at the cell surface (23, 24, 62, 63). While extra-Golgi distributions of glycosyltransferases have been described, there is as yet little evidence that cell-surface or secreted transferases directly contribute to cell-cell recognition or adhesion in the nervous system (64-67). Rather, the search for proteins that might exploit cell surface glycans to generate adhesion has focused on identifying true lectins, proteins that have as their primary function the binding of specific oligosaccharides (68, 69) .
The ability of dissociated cells to sort into homotypic clusters based on differential adhesiveness encouraged attempts to identify topographic specificity in adhesive preferences within the nervous system (70) (71) (72) . In particular, analysis of cellular interactions in the chick retinotectal projection provided an early indication that carbohydrate-mediated cell adhesion could impart positional information. Roth and Marchase demonstrated that the adhesive preferences of cells derived from distinct topographic regions of the retina for appropriate complementary regions of the tectum could be perturbed by biochemical treatments (24). Among these treatments, incubation of the retinal surface with an exoglycosidase (beta-Nacetylhexosaminidase) impaired the ability of dorsal retinal cells to discriminate ventral from dorsal tectum, suggesting that carbohydrate-mediated interactions contribute to positional adhesive preferences (62). Subsequently, quantification of retinal cell adhesion to purified neural glycoconjugates established that retinal cells can distinguish between oligosaccharide structures on apposed surfaces (73) .
The putative lectin responsible for neural retinal cell adhesion to carbohydrate has yet to be identified although other lectin activities have been characterized in several contexts within the nervous system ( Figure 2 and Table 1 ) (69, (74) (75) (76) (77) . 
Galectin scaffolds modulate signaling and mediate interactions with growth substrate
Galectins are a family of secreted carbohydrate-binding proteins that have been implicated in apoptosis, leukocyte activation, tumor metastasis, and pre-mRNA splicing (78, 79) . The preferred ligand for most members of the family is lactosamine (Gal-beta1,4GlcNAc), which is found on glycans in N-and O-linkage to numerous proteins, including laminin, NCAM, and fibronectin (80) . The best characterized members of the family are Galectin-1, which contains a single carbohydrate binding domain (CRD), and Galectin-3, which has a C-terminal CRD and an N-terminal extension that facilitates multimerization (Figure 3 ). Galectin dimerization forms homodimers capable of crosslinking bound molecules bearing appropriate glycans (81) . Both Galectin-1 and Galectin-3 are proposed to modulate signal transduction events by binding lactosamine moieties on cell surfaces, forming a lattice-like network of crosslinked glycoconjugate (81, 82) . The lattice either promotes or inhibits signaling, depending on which components are brought together or kept apart by the resultant galectinglycoconjugate mesh (83) .
For example, Galectin-1 modulates apoptosis in T-cells through its interactions with elements of the extracellular matrix (84) . In this context, Galectin-1 binds lactosamine-bearing matrix proteins, sequestering the CD45 protein tyrosine phosphatase receptor away from its ligand and thereby initiating apoptosis (84) (85) (86) .
Although the formation of galectinglycoconjugate lattices has not yet been demonstrated in neural tissue, galectin function has been implicated in the regulation of neuronal cell death, axon-axon, and axonsubstrate interactions. Mice lacking beta1,3GlcNAcTI (beta1,3-N-acetylglucosaminyltransferase I), a key enzyme in the synthesis of lactosamine-containing glycans, exhibit loss of a subset of primary olfactory neurons and consequent perturbations of olfactory bulb organization (87, 88) .
Furthermore, monoclonal antibodies have demonstrated the presence of lactoseries oligosaccharides on NCAM expressed in the olfactory epithelium and bulb. Biochemical perturbations of these glycans, which are favored ligands for endogenous galectins, result in altered axon fasciculation of the olfactory neuron projection to the olfactory bulb (57). Multiple galectins are found in the olfactory system, consistent with the proposal that galectinmediated glycan recognition facilitates the axon-axon and axon-glial interactions which underlie sorting events that are necessary for appropriate sensory innervation (89-92). These recent findings echo earlier descriptions of glycans and galectins in dorsal root ganglia and the sensoryreceptive regions of the dorsal horn of the spinal cord (27, 38, 39).
Ig-domain containing lectins bind diverse glycan structures
Members of the superfamily of cell surface proteins containing extracellular Ig domains have been broadly implicated and extensively studied as adhesion molecules. A high level of functional conservation across species has been associated with these classic cell adhesion molecules, which mediate both homophilic and heterophilic interactions in developing and mature tissues. The activity of a subset of Ig superfamily members, designated I-type lectins, arises from their ability to bind carbohydrate.
Among the I-type lectins, the Siglec family preferentially binds sialylated glycans (sialic acid-binding Ig superfamily lectin). Individual Siglecs possess differing capacities to discriminate between NeuAc in alpha2,3 linkage to Gal, alpha2,6 linkage to Gal/GalNAc, or alpha2,8 linkage to NeuAc, but all family members possess (Figure 4 ). With 16 of these C2 domains, the founding member of the Siglec family, Siglec-1 (Sialoadhesin), is the most highly extended Siglec. Expressed by macrophages, Siglec-1 binds sialylated glycans on differentiating and mature erythroid and myeloid cells, leading to differential activation, survival, or cell death (93, 94) . In contrast, members of the CD33 subfamily of Siglecs (Siglec-3, Siglec-5 through -10, and human Siglec-11) possess only 2 -5 Ig domains. These less extended extracellular domains are consistent with proposals that members of the CD33 sub-family are locked into cis-interactions with sialylated glycans on the surface of the cell on which they are expressed. In response to pathogen invasion or other signals that alter cellular sialylation, CD33 family members are liberated to interact in trans with ligands on appropriate effector cells.
Siglec-1 and Siglec-11 (human only) have been detected in neural tissue, where they are expressed by macrophages in the PNS or by microglia-like cells in the CNS. The Myelin Associated Glycoprotein (MAG), now designated Siglec-4a (95) , is more broadly expressed in neural tissue than Siglec-1 or Siglec-11, reflecting its crucial function in axon-glial interactions (section. 4.2.1., below). The convergence of studies on the binding specificity of non-neural and neural Siglecs has led to recognition of the shared features that define the Siglec family (6, 96). To a significant extent, in vitro analysis of Siglec binding specificity has now given way to the characterization of functionally-relevant ligands (see below) that are endogenous to specific tissues (6, 55, 97, 98).
Other proteins of the immunoglobulin superfamily have also been proposed to possess I-type lectin activity, although with specificity for diverse, usually non-sialylated glycan structures (Figure 4 ). The Neural Cell Adhesion Molecule (NCAM) and multiple FGF receptors bind heparin/heparan sulfate, a property proposed to be in common with Siglec-4a (54, 99, 100). In addition, a glycan binding activity specific for high-mannose oligosaccharides has been mapped to a single Ig-like domain on NCAM (section 4.2.2., below). The P0 protein is a major component of myelin and contains only a single Ig-like domain, which mediates homophilic P0-P0 interactions necessary for myelin formation and stability. N-linked glycosylation of P0 with complex glycans, but not with high-mannose glycans, has been suggested to enhance homophilic interactions (101, 102) . Although X-ray crystal structures demonstrate that polypeptide-polypeptide contacts can account for P0-P0 interactions, cell binding and recombinant protein binding data indicate that P0 can recognize sulfoglucuronosyl oligosaccharides (HNK-1 epitopes), a class of glycans sometimes found at the single N-linked addition site on P0 (99, 103, 104) . Finally, ICAM-1 is a cell adhesion molecule of macrophages, vascular endothelial and smooth muscle cells, that binds beta2 integrin (LFA-1) on leukocytes. Brain capillary endothelial cells, astrocytes, and microglia express ICAM-1 in response to inflammatory stimuli, leading to the recruitment of circulating leukocytes into the brain parenchyma (105) . Of the five Ig-like domains found in ICAM-1, integrin-binding capacity has been mapped to domains 1 and 3, while separate domains impart binding to hyaluronic acid, a major component of the brain extracellular matrix (99, (106) (107) (108) (109) .
The diversity of glycan structures that are recognized by I-type lectins, from N-linked high-mannose oligosaccharides to glycosaminoglycans, is consistent with the broad range of interactions that have been attributed to the Ig-domain superfamily members. The Ig-like domain has proven to be a molecular architecture capable of adapting to many different needs and specificities (110) (111) (112) . Two examples of particular interest for neural cell interactions are discussed in greater detail below.
Siglec-4a interacts with lipid-linked glycans to maintain axon integrity
Siglec-4a binds sialic acid linked alpha1,3 to the Gal residue of the T-antigen (Gal-beta1,3GalNAc), a structure found at the non-reducing terminus of a subset of ganglioside glycosphingolipids (113, 114) . The most potent ganglioside ligands for Siglec-4a, designated GD1a and GT1b, are enriched in the extracellular leaflet of the axonal plasma membrane, where they are positioned to mediate oligodendrocyte-axon interactions (115) (116) (117) (118) . Accordingly, axonal degeneration, secondary to the destabilization of a structured myelin sheath, is a phenotype shared by knockout mice that lack Siglec-4a or that are deficient in the biosynthesis of complex gangliosides (55, 119-121).
Knock-out phenotypes indicate that the interactions between Siglec-4a and specific neuronal glycan structures stabilize formed axonal pathways. At least in part, this stabilization is a direct consequence of inhibited axon outgrowth. Along with at least two other defined protein components of myelin, NOGO and OMgp, Siglec4a contributes to the ability of CNS myelin to inhibit axon outgrowth (122) (123) (124) (125) . The inhibitory activity of all three proteins may converge on a small family of related NOGO receptors, designated NgR1 -3 (126, 127) . The identified NgR family members possess conserved structural features, including extracellular leucine-rich repeat motifs. Recent work has attempted to define the structural characteristics that might provide NgR's with the capacity to discriminate between the three inhibitory ligands of myelin (128, 129) . In particular, NOGO, OMgp, and Siglec-4a all bind to NgR1, but conflicting reports suggest that NgR2 may or may not preferentially interact with Siglec-4a. In this context, the interaction of Siglec-4a with NgR2 exhibits sialic acid-dependence and neuraminidase-sensitivity, suggesting that glycosylation of NgR2 may yield structures that can be recognized by Siglec-4a (130) . In fact, the most potent glycan ligands for Siglec-4a, sialyl T-antigen and disialyl T-antigen, are frequently found O-linked to glycoproteins, not just on glycolipids. However, recent work has demonstrated that axon outgrowth from neurons lacking O-linked glycosylation remains sensitive to glycandependent inhibition by myelin preparations (131, 132) .
In characterizing myelin inhibitory factors, experimental approaches have utilized receptor/ligand probes of differing valencies and myelin prepared by alternate protocols, generating results that are not always in agreement with each other. Adding to this confusion, mouse knock-outs that lack Siglec-4a, NOGO, or NgR1 do not consistently result in the production of CNS myelin that is permissive for axon outgrowth (55, 119, [133] [134] [135] [136] . In some part, these experimental discrepancies and unexpected results indicate that the mechanisms underlying myelin inhibition of axon outgrowth are probably overlapping; loss of a single activity is insufficient to completely lift the blockade. The activation of NgR-ligand complexes likely requires the coordination of multiple components, including co-receptors and the association of favored gangliosides within appropriate lipid microdomains (137) (138) (139) (140) . Thus, interactions between Siglec-4a and glycans may not only subserve signaling and adhesive functions, but might also facilitate the organization or stabilization of membrane microdomains required for appropriate glial-axon interactions.
Glycan recognition by NCAM
The function of NCAM (Neural Cell Adhesion Molecule), one of the founding members of the immunoglobulin superfamily of adhesion receptors, is intricately linked to glycan expression in at least three different ways. First, the homophilic adhesive activity of NCAM is modulated spatially and temporally by the elaboration of a large anionic polymer of alpha2,8-linked sialic acid at a preferred glycosylation site (section 5.2, below), which sterically hinders NCAM-NCAM protein contact (141) . Second, a heterophilic binding site on NCAM (Ig-like domain 1) for heparin/heparan sulfate/chondroitin sulfate overlaps the homophilic proteinprotein interaction domains (Ig-like domains 1 and 2), establishing a mechanism for limiting NCAM-NCAM adhesion by competitive recognition of extracellular matrix components (142) . Third, NCAM interacts in cis with the L1 adhesion molecule by binding high-mannose N-linked oligosaccharides on L1. Glycan-mediated interactions between NCAM and L1 on the same cell surface enhance L1-mediated homophilic interactions between cells (100). Thus, a single Ig superfamily member directly depends on appropriately regulated glycan expression to modulate function through its own glycosylation, to interact in trans with heterophilic glycan ligands, and to form critical glycan-mediated associations in cis with other receptors.
The lectican family of proteoglycans organizes brain extracellular matrix by interacting with protein and glycan ligands
In comparison to other tissues, the extracellular matrix of the brain is most notable for what it lacks. Distinct, stress-bearing fibrils and structural components composed of proteins such as collagen and elastin are absent. Rather, the extracellular matrix of the neural parenchyma is rich in laminin, hyaluronic acid, chondroitin sulfate, and heparan sulfate. Among the proteoglycans, some members of the lectican family, notably neurocan and brevican, are largely restricted to neural tissue (30, [143] [144] [145] . The modular structure that defines the lectican family (which includes aggrecan and versican in addition to neurocan and brevican) also describes molecules ideally suited for cross-linking matrix components ( Figure 5 ). Both ends of the canonical lectican structure can bind glycan. The amino-terminal globular domains (designated G1 and G2) are structurally similar to cartilage link protein and CD44, allowing this end of the lecticans to bind hyaluronic acid. At the other end, the carboxyl-terminal globular domains (designated G3) possess motifs characteristic of C-type lectins, including a carbohydrate recognition domain (CRD), EGF repeats, and complement regulatory repeats (CRR).
The G3 domain has been proposed to interact with glycans on Tenascin-R, a secreted, multivalent extracellular matrix protein (146) .
However, both deglycosylated (or non-glycosylated) Tenascin as well as bacterially-expressed Tenascin-reporter fusion proteins bind lectican with affinities in the nanomolar range, indicating that protein-protein interactions may dominate the binding (147) .
Despite their conserved domain structure, the lecticans are not equivalent binding partners; the affinity of the Brevican G3 domain for Tenascinreporter fusions was 10-fold or more greater than the affinity of G3 domains from other lecticans. Individual lectican G3 domains also exhibit distinct, glycanindependent preferences for components of non-neural extracellular matrix proteins, most notably the Fibulins (148) . Therefore, it remains to be determined whether lecticans utilize their C-terminal domains as lectins in vivo, perhaps as regulators of protein-protein interactions (149) . Nonetheless, lectican G3 domains clearly bind a subset of glycans frequently found as glycosphingolipids in neural tissue. The most potent glycan ligands identified in vitro, sulfatide and sulfoglucuronosyl glycosphingolipids, possess a sulfated monosaccharide, either Gal or GlcA (150) . The identification of endogenous, potent, glycan ligands may help to clarify the relevance of the lectican lectin activity.
A central core of variable length, containing multiple attachment sites for O-linked glycans, separates the two glycan binding domains of the lecticans. The diversity of O-linked glycans is not completely defined on the lecticans, but includes glycosaminoglycan chains (primarily as chondroitin sulfate), extended core-1 type structures that are sensitive to O-glycosidase following sialidase treatment, as well as atypical O-linked glycans, including sulfoglucuronosyl-containing HNK-1 epitopes, that are resistant to a range of endo-and exoglycosidases but are sensitive to beta-elimination (151) (152) (153) . Glycans attached to the lectican central domain mediate interactions with glycosaminoglycan-binding proteins, including Pleiotrophin (HB-GAM) and Amphoterin, which also binds sulfoglucuronosyl glycans (154, 155) .
Taken together, the combined activities of the individual lectican domains are sufficient to propose that members of this carbohydrate-binding protein family organize the extracellular matrix in the nervous system. Interactions between lectican, hyaluronic acid, and tenascin have been proposed to generate organizational building blocks that can be constructed with varying degrees of crosslinking, depending on the local concentration of each component (145) . A specialized elaboration of the brain extracellular matrix, called the perineuronal net, invests extrasynaptic neuronal surfaces with a mesh-like coating (42, 156). Perineuronal nets have been characterized immunochemically and demonstrate significant regional, developmental, and activity-dependent heterogeneity in the content and post-translational modification of constituent aggrecan, brevican, neurocan, chondroitin sulfate, and tenascin forms (153, (157) (158) (159) . Extremely interesting questions remain regarding whether the mechanisms that control extracellular matrix deposition are different from those that regulate perineuronal net formation (160-163). The answers will be relevant for understanding synaptic plasticity, neuronal regeneration, and tumor cell metastasis.
CARBOHYDRATE MODULATORS
All neural cell adhesion proteins are glycosylated. The extent to which glycan addition to these polypeptides influences their function is beginning to be understood in several contexts (Figure 6 ).
In the endoplasmic reticulum of all cells, the co-translational addition of glucosylated, high-mannose oligosaccharide to asparagine residues is required for the appropriate folding and processing of most proteins destined for the cell surface (164). Therefore, loss of protein function that arises simply from loss of N-linked glycan addition must be carefully evaluated to ensure that protein folding and is modulated by interactions between cell surface proteins such as alpha-dystroglycan (i) and matrix proteins much as laminin (j). Altered glycosylation of alpha-dystroglycan (i') affects its interaction with extracellular matrix, generating adhesive differences or specific signals that modulate cell migration. relevant glycan structures have been characterized (Table  1) .
Sulfated GalNAc modulates hormone activity
The terminal N-linked carbohydrate structure SO 4 -4-GalNAc-beta1,4GlcNAc was originally identified on lutropin (LH), thyrotropin (TSH) and other glycoprotein hormones secreted from the pituitary gland (165). While terminal beta1,4-linked GalNAc is recognized by the asialoglycoprotein receptor on hepatocytes, GalNAc-4-SO 4 preferentially binds the mannose receptor on hepatic endothelial cells (166-168). The differential affinities of these receptors for sulfated or non-sulfated glycans regulates the rate of LH clearance from the blood, which is critical for embryo implantation (169).
Generation of the terminal sequence SO 4 -4-GalNAc-beta1,4GlcNAc requires the coordinated expression and targeted activity of two transferases. Beta1,4GalNAc transferase catalyzes the addition of GalNAc to terminal GlcNAc on N-linked glycans of several glycoprotein hormones (170). Subsequently, a GalNAc-4-sulfotransferase (GalNAc-4-ST1 or GalNAc-4-ST2) adds a sulfate moiety to the 4-position of the terminal beta1,4-linked GalNAc (171-173). GalNAc-4-ST1 is predominantly expressed in fetal and adult brain, particularly in the pituitary gland, and is thought to account for GalNAc-4-sulfation on LH (174). GalNAc-4-ST2 is primarily expressed in the trachea. A neural role for sulfated glycans is supported by the detection of beta1,4GalNAc-transferase and GalNAc-4-sulfotransferase activities in the cerebral cortex, midbrain, and cerebellum (175).
GalNAc-4-SO 4 is abundant on the extracellular matrix cell adhesion molecule Tenascin-R (TN-R) in the rodent cerebellum, hippocampus, and cortex, as well as in the neuroblastoma cell line SH-SY5Y (176, 177) , suggesting this glycan has a CNS function beyond hormone regulation. Tenascin-R is thought to play a role in postnatal and adult neurite outgrowth and synaptogenesis by interacting with a variety of receptors (178) . Its posttranslational modifications, which include the HNK-1 epitope and chondroitin sulfate GAGs in addition to GalNAc-4-SO 4 , are highly regulated and likely modulate interactions between Tenascin and its receptors (177) . Specifically, Tenascin-R carrying sulfate modification is upregulated in the cerebellum at postnatal day 15 and remains high in the adult. Correspondingly, cerebellar GalNAc-4-SO 4 is restricted to the molecular and Purkinje cell layers and is upregulated during peak periods of synaptic remodeling (176) . In contrast, the HNK1 epitope and HNK1-modified Tenascin-R are downregulated following postnatal development, indicating distinct functions for each carbohydrate modification (177) .
Molecular interactions between GalNAc-4-SO 4 and other neural cell surface or matrix components have not yet been characterized. In addition to Tenascin-R, at least three other unidentified glycoproteins are modified by GalNAc-4-SO 4 in the neuronal cell line SH-SY5Y, raising the possibility that the sulfated glycan may possess activity independent of the protein to which it is attached (177). It is, at present, not clear whether the glycan functions only to modulate ligand-receptor interactions, or might also serve as a ligand itself in a lectin-mediated signaling pathway. The mannose receptor is a good candidate for a lectin that recognizes brain GalNAc-4-SO 4 (Figure 4) , as its expression is spatially and temporally regulated in neurons, astrocytes, and macrophages in mouse brain (179) . With age, mannose receptor expression becomes more pronounced in the meninges, brain stem, upper layers of the cerebral cortex, hypothalamic nuclei, and notably, Purkinje cells and their processes. Analogous to its role in peripheral LH clearance, the mannose receptor in the central nervous system might influence endocytosis of Tenascin-R or other glycoproteins carrying GalNAc-4-SO 4 . Alternatively, lectin recognition of GalNAc-4-SO 4 could directly trigger a signaling pathway influencing neural development or function.
Polysialic Acid (PSA) modulates cell adhesion
In animals, polymers of alpha2,8-linked sialic acid, or polysialic acid (PSA), were first described as a substituent of a subset of glycopeptides harvested from developing rat brain by Pronase digestion, where they accounted for approximately 10% of the total proteinbound sialic acid (28). PSA is highly expressed in the developing brain and becomes restricted to areas of the adult brain that undergo active neural differentiation and synaptogenesis, such as the hippocampus and olfactory bulb. The predominant carrier of PSA is the Ig-domain containing, neural cell adhesion molecule (NCAM). Several cell culture and in vivo experiments have shown that PSA removal reduces neurite outgrowth, increases cell surface interactions with the extracellular matrix or other cell membranes, including the myelin sheath, and specifically modulates NCAM-mediated homophilic and heterophilic adhesion (180) (181) (182) (183) .
Three isoforms of NCAM are expressed in the nervous system. Transgenic mice in which NCAM-180, the longest isoform, is deleted display defective migration of granule cells into the olfactory bulb from the subventricular, rostral migratory stream (184) . Targeted disruption of exons 3 and 4 of NCAM results in drastically reduced expression of a truncated NCAM transcript and elimination of all detectable NCAM protein in mouse brain extracts, as well as an 85% reduction in PSA levels. The major anatomical consequences of this disruption are a 10% reduction in brain size and significant shrinkage of the olfactory bulb granule cell layer.
Reciprocal cell transplantation, between wild-type and NCAM mutant mice, revealed that PSA is required in the subventricular field, rather than in the migrating cells and in vitro migration assays are consistent with this conclusion (185) . These anatomical phenotypes support the proposal that polysialic acid on NCAM modulates interactions between cells by disengaging adhesion, thereby facilitating migration.
Differences in exploratory behaviors and maze learning have been described in mice that lack NCAM or that lack either one of the two sialyltransferases capable of polymerizing sialic acid (29, [186] [187] [188] [189] [190] [191] [192] [193] . In addition, altered NCAM and PSA levels have been correlated with changes in long-term potentiation, long-term depression, and mossy fiber input into the hippocampus. At least two possible mechanisms might explain how altered PSA expression could impact functional neural circuitry. PSA may directly affect synaptic transmission, or neurons that lack PSA may be subject to inappropriate input from aberrantly stabilized synapses that would otherwise be eliminated through dampened adhesion.
Unfortunately, the redundancy resulting from the existence of two PSA synthetic enzymes (designated ST8SiaIV and ST8SiaII) has made it difficult to assess the effect of complete loss of PSA. Recently, however, the double polysialyltransferase knock-out has been characterized (194, 195) .
Complete loss of polysialylation phenocopies the morphological and behavioral deficits of the NCAM knock-out, but also affects additional brain structures and leads to precocious death. Triple knockouts, that lack NCAM and two polysialyltransferases, appear wild type, indicating that the primary function of PSA is to modulate the potential for naked NCAM to induce gain-of-function complications.
Developmental cell fate decisions are modulated by appropriate glycosylation of Notch signaling components
Notch proteins are functionally and structurally conserved transmembrane receptors required for cell fate determination in multiple tissues and species (196) . The ability of Notch mutations to generate altered patterns of neural cell differentiation was first described in Drosophila, but has been extensively characterized in vertebrates as well. In response to ligand binding, the Notch protein undergoes juxtamembrane and intracellular cleavage to liberate its intracellular domain (ICD). The Notch ICD translocates to the nucleus where it partners with proteins of the CSL family (human CBF-1, Drosophila Suppressor of Hairless, worm Lag1) to form a co-activation complex that regulates effector molecules controlling cellular differentiation (197) . The extracellular domain of Notch contains multiple EGF repeats, which interact with ligands (Delta or Serrate/Jagged) and are modified by the addition of both N-and O-linked glycans. An O-fucosyltransferase (OFUT1 or POFUT1) is responsible for the transfer of Fuc to serine/threonine within some EGF repeats (198) (199) (200) (201) (202) . A subset of these fucosylated sites are, in turn, substrates for the action of the Fringe protein, an Nacetylglucosaminyltransferase that transfers GlcNAc in beta1,3-linkage to O-linked Fuc. Further extension of the disaccharide has not been described in Drosophila. In vertebrates, however, the GlcNAc-beta1,3Fuc-Ser/Thr modification can be extended by galactosylation and sialylation (203) (204) (205) (206) .
Loss of OFUT1/POFUT1 activity phenocopies Notch mutations in Drosophila and in mice, demonstrating that modification with O-linked glycans is essential for appropriate temporal and spatial activation of Notch signaling. The specificity of signaling is further modulated through Fringe-catalyzed glycan extension. Addition of GlcNAc by Fringe alters Notch's binding affinity to favor Delta interactions at the expense of Serrate/Jagged binding (207, 208) . Such ligand binding preferences generate domains of differential Notch signaling that establish tissue compartment boundaries. For instance, Fringe-mediated modulation of Notch activation leads to differential dorsal/ventral expression of Vestigial and Wingless in the developing Drosophila wing disc. Furthermore, cyclic activation of Fringe along the anterior/posterior axis of the mouse presomitic mesoderm generates spatio-temporal patterns of Wnt-induced differentiation that are necessary for the regular pattern of somite formation (209) (210) (211) .
In addition to binding Delta and Serrate/Jagged ligands on apposing cells, Notch can also interact with ligands expressed on the same cell. Such cis interactions with ligands alter the responsiveness of cells to local cues by repressing Notch signaling (212) .
Although the molecular mechanism is not completely understood, Fringe activity releases cis inhibition, indicating that Fringe can modulate Notch signaling by affecting transcellular and intracellular ligand binding. As predicted by the synthesized glycan structure, Fringe modulation of signaling requires the OFUT-catalyzed addition of Fuc to Ser/Thr residues on Notch (198, 201) . Recent evidence indicates that OFUT is also necessary for correct folding and subsequent trafficking of the Notch protein in Drosophila. Mutant OFUT forms that lack enzymatic activity are still capable of facilitating Notch maturation in the endoplasmic reticulum, indicating a glycanindependent, chaperone-like function for the enzyme (213) . It remains to be determined whether the effect of Fringe on Notch signaling might, in part, arise from altered trafficking through secretory or endosomal pathways.
O-linked glycans modulate the integrity of the Dystrophin Glycoprotein Complex
In parallel with the realization that Notch signaling is modulated by a specific set of O-linked glycans, it has also become apparent that other O-linked structures critically affect the activity of membrane proteins. In the case of alpha-dystroglycan, altered glycosylation at Ser/Thr residues contributes to the pathophysiology of several inherited forms of muscular dystrophy in humans (214) (215) (216) . The nature and severity of the pathology are determined by the manner in which Olinked glycosylation is affected.
In muscle, alphadystroglycan is at the core of the dystrophin glycoprotein complex, a large assembly of proteins responsible for linking together the muscle cytoskeleton, sarcolemma, and the extracellular matrix. Therefore, appropriate assembly and function of the complex is essential for transducing force generated by actin/myosin. In the nervous system, alpha-dystroglycan is expressed by glia and neurons throughout the developing and mature brain and has been implicated in controlling cellular migration, reinforcing synaptic connections, and stabilizing glial associations (216-220).
The alpha-dystroglycan molecule possesses a central mucin-like domain that is rich in glycosylated Ser/Thr residues. A comprehensive profile of the glycan diversity on alpha-dystroglycan is yet to be determined but has been demonstrated to vary depending on tissue source. Among the O-linked glycans found on alpha-dystroglycan are some expected mucin-like structures (GalNAc alone, the core-1 disaccharide Gal-beta1,3GalNAc, and NeuAcalpha2,6GalNAc) as well as a family of less wellcharacterized, but broadly distributed, glycans linked to Ser/Thr through Man rather than GalNAc (221, 222) . Underglycosylation of alpha-dystroglycan, due to loss of the enzyme responsible for Man addition to Ser/Thr (POMT1, protein O-mannosyltransferase I), results in Walker-Warburg Syndrome, a severe form of muscular dystrophy with CNS malformation. O-linked Man residues on alpha-dystroglycan are frequently extended by the addition of GlcNAc, Gal, and NeuAc to generate a tetrasaccharide (NeuAc-alpha2,3Gal-beta1,4GlcNAc-beta1,2Man-Ser/Thr) or a more complex branched glycan. Loss of the GlcNAc transferase that adds GlcNAc in beta1,2 linkage to Man (POMGnT1, protein O-mannose GlcNAc transferase I) results in Muscle-Eye-Brain disease, a form of muscular dystrophy less severe than WalkerWarburg but still of significant consequence. Although transferases responsible for extension or branching of GlcNAc-beta1,2Man-Ser/Thr have yet to be conclusively identified, several milder forms of muscular dystrophy (Fukuyama Type MDC, Limb-Girdle MDC-1c, and MDC1d) have been associated with mutations in glycosyltransferase-like proteins (Fukutin, Large) of still undefined activity (214, (223) (224) (225) (226) .
The interaction of alpha-dystroglycan with laminin in the extracellular matrix, especially laminin 2, has been proposed to be carbohydrate-mediated (222, 227, 228) . If laminin possesses a lectin activity specific for Olinked Man structures on alpha-dystroglycan, loss of Olinked glycosylation might uncouple the dystrophin glycoprotein complex from its extracellular attachments. POMT1 deficiency, then, should present a very severe phenotype, as in Walker-Warburg Syndrome. Mutations that target increasingly distal processing steps (POMGnT1, or yet-to-be identified GalT and SiaT activities) should present less severe phenotypes if the resulting truncated glycan profiles are able to confer partial binding activity (Muscle-Eye-Brain Disease, Limb-Girdle Muscular Dystrophy).
Thus, the O-linked glycans on alphadystroglycan may serve primarily as ligands for matrix adhesion. Alternatively, interactions between laminin and alpha-dystroglycan may generate signals that lead to specific cellular responses (229, 230) . Propagated signals may be attenuated or enhanced, similar to the severity of phenotypes associated with partial loss-of-function mutations, by the type of glycans elaborated on a population of alpha-dystroglycan molecules.
Thus, whether the primary mechanism is adhesion or signaling, cells can invoke changes in their glycosylation profile to modulate interactions with their environment.
CARBOHYDRATE CO-RECEPTORS
Biological processes that change cellular behaviors unfold in sequences of small steps. Each step provides an opportunity for integrating regulatory signals that either reinforce or block continuation along a pathway. In several such contexts, glycans mediate early events that initiate, or at least facilitate, cascades of signals and responses (Table 1) . As ligands for specific binding proteins, glycans can function as molecular co-receptors that present effector molecules in a biologically active form. As specific cell adhesion ligands, glycans can function as cellular co-receptors, allowing signals to pass between appropriately apposed cells. Therefore, the largely uncharacterized mechanisms that regulate specific glycan expression provide checkpoints that allow cells to reevaluate their commitment to processes that utilize glycans as co-receptors (231) (232) (233) . In the nervous system, the activity of glycan co-receptors is evident in controlling cell proliferation, regulating axon guidance, and facilitating intercellular signaling.
Glycosaminoglycan co-receptors influence neural cell proliferation
The range of tissues, cells, and molecules, whose functions are influenced by proteoglycans, is almost as diverse as the immense structural variation inherent in the glycosaminoglycan family. Signaling pathways that utilize TGFs/BMPs, FGFs, Hedgehogs, Wnts, as well as Slit-like proteins are all modulated by GAG co-receptors, especially of the heparan sulfate family. Accordingly, mutations that broadly affect GAG synthesis engender severe patterning and cell-fate phenotypes (234) (235) (236) (237) (238) . For example, the EXT1 protein is a heparan sulfate synthetic enzyme that copolymerizes GlcA and GlcNAc to generate a backbone of the unmodified disaccharide repeat, (GlcAbeta1,4GlcNAc) n . Conditional deletion of the EXT1 gene in the mouse nervous system results in perinatal death due to multiple brain deformities. EXT1-null mice lack inferior colliculi and cerebella and present expanded expression domains of FGF8 and its downstream targets, En and Wnt1, at the midbrain-hindbrain boundary. These phenotypes are consistent with a role for heparan sulfate as a co-receptor that stabilizes a gradient of FGF morphogen. The cerebral cortex in EXT1-null mice is also smaller than controls, reflecting reduced FGF-stimulated cell proliferation, and axon guidance through major brain pathways is disrupted, reflecting the co-receptor activity of heparan sulfate in Slit-Robo signaling (see below) (237, (239) (240) (241) (242) .
Heparan sulfate chains on proteoglycans are subject to de-N-acetylation, epimerization, and selective sulfation at various positions, generating structural diversity beyond polymerization of the Nacetylglucosamine and glucuronic acid backbone (243) . A central question, of great relevance to the specificity of proteoglycan function in neural tissue, is whether individual signaling molecules utilize discrete GAG structural domains (with characteristic epimerization and sulfation profiles) to achieve differential signaling across distinct brain regions (244, 245) . So far, favored heparan sulfate structural motifs have been defined for only a small number of interacting proteins. Among these defined structures, the FGF-2/FGF receptor complex prefers two binding motifs. One motif consists of a pentasaccharide enriched in N-sulfated GlcN, a single 2-O-sulfate on an epimerized GlcA (IdoA), but lacking 6-O-sulfate (211, (246) (247) (248) . The other motif is characterized by the presence of 6-O-sulfated GlcN (249, 250) .
The specificity of another heparan sulfate binding protein, Pleiotrophin (HB-GAM, OSF-1), has not been structurally defined but appears to overlap with that of FGF-2, especially for heparan sulfate chains on the transmembrane proteoglycan syndecan-3/Nsyndecan (251) .
Pleiotrophin contains two type-1 thrombospondin repeat (TSR) domains and is secreted into the extracellular matrix of brain and other tissues (155) . Pleiotrophin is also highly expressed in the ventricular zone of the developing cerebral cortex where it is proposed to inhibit cell proliferation by competing with FGF-2 for heparan sulfate binding sites, thereby blocking activation of the FGF receptor (251) . Consistent with this proposal, loss-of-function mutations in FGF-2 result in decreased cortical cell density, while Pleiotrophin knock-out mutations exhibit increased cell density in the same cortical layers (251) (252) (253) . Interestingly, loss of heparan sulfate 2-O-sulfation in mice that lack the 2-O-sulfotransferase (mHS2st), results in decreased proliferation of cortical cell progenitors, thereby phenocopying the FGF-2 knock-out (254) . Thus, specific sulfation patterns of heparan sulfate act as co-receptors for FGF signaling in the nervous system and this potentiation can be modulated by small heparan sulfate binding proteins distributed in the extracellular matrix. In non-neural tissues, different structural specificities may dominate. FGF-2 signaling is not impaired by loss of 2-O-sulfate in embryonic fibroblasts derived from Hs2st knock-out mice and elimination of 6-O sulfate in Drosophila, due to loss of the 6-O-sulfotransferase (dHS6st), eliminates FGF signaling through the FGF receptor gene, breathless (255) (256) (257) . The fine specificity of glycosaminoglycan co-receptor activities will ultimately reflect the regulation of glycan synthetic enzymes in each tissue. Neural glycans function as co-receptors that facilitate or attenuate signaling. Three sequential stages (1,2,3) are depicted as two neurons navigate a growth surface and respond differentially to local cues. Two neurons initially extend over similar terrains (a on left and right sides in 1). As they approach choice points, defined by the presence of attractive (b, green) or repulsive (c, red) growth factors, neurite extension is facilitated by adhesive interactions between lectins and broadly distributed glycans (d). In this diagram, both neurons express lectins (e) that recognize glycans present on non-neural cells at the choice point (e'). Alternatively, the lectin could be expressed by non-neural cells at the choice point and recognize neural glycans. Each neuron expresses receptors (f,f') that distinguish attractive from repulsive cues. Interactions between growth factors and extracellular matrix co-receptors (g) determine the efficacy and may alter the nature of the signal. Lectin-carbohydrate interactions at the choice point (2) facilitate signaling by bringing receptors into proximity with the source of attractive or repulsive factor (h,i). Signal transduction leads to appropriate responses (j,k in 3). Glycans acting as co-receptors insure the fidelity of axon pathfinding by facilitating interactions that transmit local cues.
Glycosaminoglycan co-receptors influence axon guidance
Axon guidance during development and regeneration requires the coordinated activity of many genes (258, 259) . Cellular adhesion must be modulated and growth signals must be conveyed in an appropriate spatial and temporal sequence to allow directed axon outgrowth (Figure 7) . Both positive and negative signals are required to keep axons moving in the right direction. Originally characterized in Drosophila, Roundabout (Robo) receptors sense local cues that repel axons of Roboexpressing neurons away from the repulsive source (260) . In the Drosophila embryo, the Slit protein is the repulsive cue and the source is a set of glial cells at the midline of the embryonic nervous system (261) .
Thus, Robo-Slit interactions keep a subset of neurons from sending axons across the midline. Other neurons, that do not express functional Robo, ignore the Slit signal at the midline and proceed to the contralateral side. Multiple vertebrate Robo and Slit homologues demonstrate analogous pathfinding functions (262) .
Based on the ability of heparinase digestion to reduce Slit binding to Robo-expressing cells, it was proposed that cell surface heparan sulfate is required for Slit-Robo binding and, consequently, for cells and axons to respond to the Slit repulsive cue (263) . Neither Slit nor Robo have been shown to bear heparan sulfate, suggesting that a heparan sulfate proteoglycan functions as a coreceptor to maximize Robo-Slit signaling. Genetic and molecular evidence now supports this role for proteoglycans.
Two labs have demonstrated that Drosophila Syndecan (Sdc) genetically and physically interacts with Slit and is required for appropriate midline axon guidance (264, 265) . Mutants in sdc suffer midline axon fasciculation and guidance defects that mimic robo and slit mutant phenotypes and that are rescued by panneural expression of Sdc. Expression of Sdc by midline cells in sdc mutants did not rescue the guidance defects, demonstrating that Syndecan is specifically required as a co-receptor in Robo-expressing cells (264, 265) .
The mechanism by which Sdc functions as a coreceptor remains to be determined. While Slit secretion from midline glia is normal in sdc mutants, its spatial distribution (or its stability in the neuropil) is significantly altered, suggesting that Sdc normally concentrates Slit near developing axons (264) . Robo, Slit, and Syndecan can be co-precipitated from Drosophila extracts, and vertebrate Slit proteins bind proteoglycan affinity matrices, consistent with the formation of a ternary signaling complex of receptor, ligand, and proteoglycan (264, 266, 267) . Based on the observation that neuronal overexpression of a glypican (Dally-like protein, Dlp) lacking a cytoplasmic signaling domain compensates for loss of Sdc, the functionally important component of the proteoglycan coreceptor appears to be the glycosaminoglycan rather than its protein carrier (264) . However, the ability of one proteoglycan core protein to substitute for another is not universal in all tissues or developmental contexts; while sdc and dlp phenotypes frequently overlap, they also display distinct characteristics that are rescued by only one of the two carriers (268) .
In C. elegans, mutations affecting a subset of heparan sulfate modifying enzymes (a glucuronosyl epimerase, a 2-O-, or a 6-O-sulfotransferase) demonstrate axon guidance defects that highlight the complexity associated with the fine tuning of axon outgrowth (245) . In one set of C. elegans neurons, the modifying enzymes are required for Slit-dependent and Slit-independent signaling through a Robo receptor. However, in other neurons Robo signaling is unaffected by the same mutations. Therefore, as in the control of FGF signaling and neural cell proliferation, the structural variation imposed on heparan sulfate proteoglycans by post-synthetic modification of their glycosaminoglycan chains, determines co-receptor specificities in axon pathfinding. It remains to be determined whether interacting proteins, such as Slit or Robo, act, at least in part, as lectins, deciphering fine variations in sulfation and epimerization patterns to achieve specific responses.
The semaphorin family of signaling molecules are bifunctional in their ability to modulate axon outgrowth. Depending on the context, semaphorins either attract or repel extending axons (259, 269) . Class 5 semaphorins are distinguished from other family members by possessing type-1 TSRs. Similar to the TSR-containing pleiotrophin molecule, class 5 semaphorins interact with proteoglycans. Heparan sulfate must be co-expressed in the same cell for attractive semaphorin 5a signaling, while the presence of chondroitin sulfate in the local environment converts semaphorin 5a from an attractive to a repulsive cue (270) . In both cases, the glycosaminoglycan functions as a spatially-restricted co-receptor that modulates signaling. Thus, the glycosaminoglycan composition of the extracellular matrix defines neuronal responses to growth signals in multiple signaling pathways.
Lectin recognition of neural glycans facilitates cellular responses
Perhaps no other family of animal lectins is as well characterized as the selectins. The selectin family of C-type lectins and their carbohydrate ligands are expressed on leukocytes, platelets and endothelial cells where they mediate the initial interactions between inflammatory cells and specialized endothelial domains in vertebrate vasculature beds (271) (272) (273) (274) . Engagement of sufficient selectin-ligand pairs induces lymphocytes to roll along the endothelium, allowing additional signaling and adhesive interactions to generate subsequent cellular responses such as extravasation into the surrounding tissue space (275).
The sequential process by which selectins initiate cellular responses provides one model for the function of carbohydrate-mediated adhesion in the nervous system. According to this model, interactions between neural cells are initiated by the engagement of specific carbohydratelectin pairs. Just as selectin-carbohydrate binding generates recognition at appropriate vascular sites, lectincarbohydrate binding in the nervous system would induce recognition between potential cellular, even synaptic partners. However, molecular, biochemical, and genetic approaches have, so far, failed to identify endogenous neural lectin families that possess sufficient diversity of function or expression to mediate the breadth of specific neural cell recognition events required for building or maintaining a functioning nervous system. With few exceptions (Siglec-4a, the lecticans, galectins in some sensory afferents), expression patterns for the known lectin types (C-type, I-type, non-sensory galectin) are dominated by their function in the cellular elements that participate in inflammatory responses, such as astrocytes, microglia, and endothelial cells of the brain microvasculature (276) (277) (278) (279) (280) (281) .
It is reasonable to ask "Where are the neural lectins capable of mediating specific cell-cell interactions?" Similar to leukocyte extravasation from vascular tissue, the specificity of cell-cell recognition in the nervous system emerges from the collective activities of multiple molecular mechanisms (258, 259) . Carbohydrate-lectin interactions are only one component of the recognition process. As such, specificity need not reside entirely in a single step. Rather, carbohydrate-lectin interactions may function primarily to bring cell surfaces together, facilitating the transmission and integration of signals that ultimately encode specificity (Figure 7) . Such a role for glycans as cellular co-receptors requires relatively few lectins to achieve specificity across the entire tissue.
A lectin expressed along the entire midline of the Drosophila embryonic nervous system illustrates this coreceptor function. The Drosophila gliolectin protein binds a subset of glycosphingolipid oligosaccharides and is expressed by the same midline glia responsible for the production of the Slit inhibitory ligand (282) . In embryos lacking the gliolectin protein, the specificity of axonal pathfinding across the midline is relatively unaffected. Axons that would normally remain ipsilateral do not cross the midline in the mutant and axons that would normally cross the midline do so in the mutant. However, ipsilateral axons are held at choice points longer than in the wild-type embryo and axons that cross the midline do so over alternative surfaces, indicating that both positive and negative signals are being transmitted but with lower efficiency (283) . Therefore, just as selectin-mediated glycan recognition initiates the process of extravasation by bringing together leukocytes and appropriately primed endothelial cells, gliolectin-mediated cell interactions ensure the efficiency of axon outgrowth by facilitating cellular signaling. At the outset of both processes, it is the presence of a glycan-lectin co-receptor mechanism that ensures the efficiency and proper localization of cellular responses.
PERSPECTIVE
The nervous system has served as a productive hunting ground, favored by glycobiologists in their search for glycan-mediated cellular interactions. The structural diversity of neural glycans seems tailor-made for establishing a combinatorial identity code that would impart appropriate specificity to interacting neurons and glia. Despite clear examples of exquisitely specific glycan expression, the existence of a simplifying glycan code is not yet apparent. Instead, the list of glycan-mediated functions has become increasingly complicated. Beyond proposed and demonstrated roles in cell adhesion and recognition, neuronal and glial glycans also modulate receptor activities and function as co-receptors that participate in ligand presentation or facilitate signal transmission. These functions are not mutually exclusive, presenting challenges for interpreting the biological effects of altered glycan expression and lectin activity.
It is conceivable that the specificity of glycanmediated interactions derives more from the mechanisms that regulate glycan expression than from the capacity of lectins to discriminate between glycan structures. In fact, major advances have been made toward understanding the breadth of glycan functions by studying mutations that impair the capacity to synthesize specific subsets of oligosaccharide structures.
Unpredicted phenotypes, including the lack of a detectable effect, have resulted from knockouts of glycosyltransferases and glycan modifying enzymes in several species (284) . Experimental strategies for deciphering these phenotypes must be capable of revealing the impact of altered glycan expression on cell function, while dissecting away the potentially complicating effects of altered glycosylation on glycoprotein structure and membrane organization. Combining approaches in novel ways, that bring together protein biochemistry, carbohydrate structural determination, and genetic analysis, will increasingly be required to discern the ligand, modulatory, and co-receptor activities of glycans in neural development, function, and pathology.
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